OncoSeek ®

Multi cancer early detection test

Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnosis is vital. Early diagnosis increases chances of survival and reduces the negative impact on quality of life. OncoInv offers OncoSeek®, a multi-cancer early detection blood test.

OncoSeek® is a low cost detection test for cancer

OncoSeek® is a software based early detection test, which analyses the concentrations of 7 protein tumor markers with an AI algorithm. It performs screening for 9 high-mortality cancers, calculating a Probability of Cancer score as wel as a predicted Tissue of Origin. OncoSeek® is scientifically validated, CE-marked and can be easily implemented as it uses existing medical infrastructure.

OncoSeek® can be used anywhere in the world by medical organisations who provide health services to the public.

About Oncolnv

OncoInv is an initiative of Inspire2Live. It’s our mission to ensure that people worldwide have early access to treatment of cancer by means of early detection. OncoInv works together with SeekIn, the developer of OncoSeek®, to reach that mission.

Oncoinv logo

News & Updates